(Q38363925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

Sick and tired: mood, fatigue, and inflammation in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Thomas B Strouse

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

1 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

Current Psychiatry Reports

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11920-015-0555-3

1 March 2020

exact match

0 references

cites work

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Depression and cancer mortality: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Management of fatigue in patients with cancer -- a practical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Biological basis of the behavior of sick animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Cytokine, sickness behavior, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Depressive disorders and immunity: 20 years of progress and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Endotoxin produces a depressive-like episode in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Ketamine for depression: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

A molecular and cellular theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Metabolic correlates of levodopa response in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Improved quality of life and function after oropharyngeal cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Resear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Methylphenidate side effects in advanced cancer: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Psychostimulants for depression in hospitalized cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

Psychiatric Symptoms in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0555-3

The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear

21 January 2018

1 reference

12 December 2020

Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

1 reference

12 December 2020

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.

1 reference

12 December 2020

Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients

1 reference

12 December 2020

Antidepressants for depression in physically ill people

1 reference

12 December 2020

Interferon-gamma-dependent/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice.

1 reference

12 December 2020

Measurement of depression in patients with cancer.

1 reference

12 December 2020

Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Depression in hospitalized cancer patients

1 reference

12 December 2020

Diagnosis of major depression in cancer patients according to four sets of criteria

1 reference

12 December 2020

Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab

1 reference

12 December 2020

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

1 reference

12 December 2020

Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes

1 reference

12 December 2020

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

1 reference

12 December 2020

Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants

1 reference

12 December 2020

Depression and degree of acceptance of adjuvant cytotoxic drugs

1 reference

12 December 2020

Psychiatric symptoms in systemic lupus erythematosus: a systematic review

1 reference

12 December 2020